Cargando…
Gypenosides ameliorate ductular reaction and liver fibrosis via inhibition of hedgehog signaling
Backgroud and aims: Ductular reaction (DR) is a common pathological change and thought to have a key role in the pathogenesis and progression of liver fibrosis. Our previous study reported Gypenosides (GPs) ameliorated liver fibrosis, however, the anti-fibrotic mechanisms of GPs are still unclear. M...
Autores principales: | Hu, Yonghong, He, Xiaoli, Zhou, Xiaoxi, Liang, Yue, Fu, Yadong, Zhang, Linzhang, Fang, Jing, Liu, Wei, Chen, Gaofeng, Mu, Yongping, Zhang, Hua, Cai, Hong, Liu, Chenghai, Liu, Ping, Chen, Jiamei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9722742/ https://www.ncbi.nlm.nih.gov/pubmed/36483737 http://dx.doi.org/10.3389/fphar.2022.1033103 |
Ejemplares similares
-
Astragalus saponins and its main constituents ameliorate ductular reaction and liver fibrosis in a mouse model of DDC-induced cholestatic liver disease
por: Zhang, Linzhang, et al.
Publicado: (2022) -
The Novel Chinese Medicine JY5 Formula Alleviates Hepatic Fibrosis by Inhibiting the Notch Signaling Pathway
por: Fu, Yadong, et al.
Publicado: (2021) -
Gypenosides Attenuate Pulmonary Fibrosis by Inhibiting the AKT/mTOR/c-Myc Pathway
por: Liu, Suqing, et al.
Publicado: (2022) -
Gypenoside L and Gypenoside LI Inhibit Proliferation in Renal Cell Carcinoma via Regulation of the MAPK and Arachidonic Acid Metabolism Pathways
por: Liu, Hui, et al.
Publicado: (2022) -
BM-MSCs overexpressing the Numb enhance the therapeutic effect on cholestatic liver fibrosis by inhibiting the ductular reaction
por: Xu, Yan-nan, et al.
Publicado: (2023)